Ziyan Luo
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: Haematologica
Published: March 04, 2026
ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: January 31, 2023
CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma.
Journal: Frontiers in oncology
Published: September 12, 2021
The dietary carcinogen PhIP activates p53-dependent DNA damage response in the colon of CYP1A-humanized mice.
Journal: BioFactors (Oxford, England)
Published: January 29, 2021
MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.
Journal: Molecular carcinogenesis
Published: January 09, 2018
Direct detection of various pathogens by loop-mediated isothermal amplification assays on bacterial culture and bacterial colony.
Journal: Microbial pathogenesis
Published: October 15, 2016
Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis.
Journal: OncoTargets and therapy
Published: June 11, 2016
miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM.
Journal: Journal of cancer research and clinical oncology
Published: March 29, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026